GMABGenmab
Slide 1 of 3
Company Overview
Name
Genmab
52W High
$35.43
52W Low
$17.24
Market Cap
Dividend Yield
0%
Price/earnings
1.22
P/E
1.22
Dividends
No dividend
Sentiment
Score
Very Bullish
93
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Additional Data
No additional data available
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Genmab
52W High
$35.43
52W Low
$17.24
Market Cap
Dividend Yield
0%
Price/earnings
1.22
P/E
1.22
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Very Bullish
93
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$0.00
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
No additional data available
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Jan G. J. van de Winkel
Location
N/A, Denmark
Exchange
Nasdaq
Website
https://genmab.com
Summary
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases.
Company Info
CEO
Jan G. J. van de Winkel
Location
N/A, Denmark
Exchange
Nasdaq
Website
https://genmab.com
Summary
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases.
